Business

STAAR Surgical Board of Directors Reiterates Unanimous Recommendation that STAAR Stockholders Vote "FOR" the Alcon Merger Agreement on WHITE Proxy Card

LAKE FOREST, Calif., October 08, 2025--STAAR Surgical Company (NASDAQ: STAA) ("STAAR"), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today provided the following statement in response to a report issued by Glass, Lewis & Co., LLC ("Glass Lewis") related to STAAR’s pending merger with Alcon (SIX/NYSE: ALC):

articleStaar Surgical CompanyOctober 8, 20258/company/staar-surgical-company/news/staar-surgical-board-of-directors-reiterates-unanimous-recommendation-that-staar-stockholders-vote-for-the-alcon-merger-agreement-on-white-proxy-card
STAAR Surgical Board of Directors Reiterates Unanimous Recommendation that STAAR Stockholders Vote "FOR" the Alcon Merger Agreement on WHITE Proxy Card

About this update from Staar Surgical Company

[{"type":"text","content":"Comments on Glass Lewis Report","length":30,"tagName":"p","attribs":{}},{"type":"text","content":"LAKE FOREST, Calif., October 08, 2025--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA) ("STAAR"), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today provided the following statement in response to a report issued by Glass, Lewis & Co., LLC ("Glass Lewis") related to STAAR’s pending merger with Alcon (SIX/NYSE: ALC):","length":422,"tagName":"p"},{"type":"text","content":"The STAAR Board of Directors and management team strongly disagree with the recommendation issued by Glass Lewis. Alcon is paying STAAR stockholders a 59% premium to the 90-day VWAP, whereas Broadwood’s proposal to vote down the merger could allow Broadwood to take control without paying any premium to other stockholders.","length":323,"tagName":"p"},{"type":"text","content":"STAAR stockholders have a choice:","length":33,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"1","rowspan":"1","style":"vertical-align:top;border-top:solid black 1.0pt;border-bottom:solid black 1.0pt;border-left:solid black 1.0pt;border-right:solid black 1.0pt;padding-left:0.0px;width:50%;","val":[{"type":"text","content":"Vote For:","length":9,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"vertical-align:top;border-top:solid black 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding-left:0.0px;width:50%;","val":[{"type":"text","content":"Vote Against:","length":13,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"1","rowspan":"1","style":"vertical-align:top;border-bottom:solid black 1.0pt;border-left:solid black 1.0pt;border-right:solid black 1.0pt;padding-left:0.0px;width:50%;","val":[{"type":"text","content":"✓ $28.00 per share all-cash offer","length":33,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"vertical-align:top;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding-left:0.0px;width:50%;","val":[{"type":"text","content":"x $18.49 per share prior to announcement","length":40,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"1","rowspan":"1","style":"vertical-align:top;border-bottom:solid black 1.0pt;border-left:solid black 1.0pt;border-right:solid black 1.0pt;padding-l...

More updates from Staar Surgical Company

STAAR Surgicalproxy statementstockholdersvision correctionSTAAR